N/A
N=81
Telehealth Group Intervention for Perinatal Depressive Symptoms
Perinatal Depression
Bottom Line
View on ClinicalTrials.gov: NCT03932760 ↗Enrolled (actual)
81
Serious AEs
0.0%
Results posted
Jun 2024
Primary outcome: Primary: Change in Depressive Symptoms Over Time — 11.11; 10.52; 7.34; 7.69 units on a scale — p=0.612
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- UPLIFT Program (Behavioral); Attention Control Group (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Utah
- Primary completion
- Mar 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Depressive Symptoms Over Time |
11.11; 10.52; 7.34; 7.69; 8.84; 8.90 | 0.612 |
| SECONDARY Change in Anxiety Symptoms Over Time |
6.97; 6.97; 5.17; 5.17; 6.31; 6.31 | 0.558 |
Summary
The goal of the project is to evaluate for the first time, the effectiveness of using a telehealth approach to reducing perinatal depressive symptoms in diverse groups of childbearing women; urban and rural-dwelling, and from Hispanic and predominantly North European Descent populations. Pregnant women connect for one hour weekly, for 8 weeks, using their own electronic device, from whatever location they choose (e.g. home), to attend videoconference groups facilitated by a mental health professional. The approach is cost effective and reduces barriers to access to mental health services, particularly for women living in rural, low-resource, and minority communities, and those without adequate transportation, financial resources, childcare, or work release time.
Eligibility Criteria
Inclusion Criteria
- women age 18 and older
- have a viable pregnancy (any gestational age) or postpartum (up to 6 months)
- have an Edinburgh Postpartum Depression Scale (EPDS) score between 9 and 20
- are English or Spanish speaking
- are receiving clinical services at a collaborating prenatal or public health clinic associated with the U of Utah or Utah rural Health Districts
Exclusion Criteria
- women who have an EPDS score less than 9 or greater than 20
- have a current diagnosis of a serious mental illness, such as psychosis, schizophrenia, bipolar disorder, severe depression, suicidal ideation, homicidal ideation
- begun taking or changed dosage of any medications for a mental health condition within the previous 6 weeks
Data sourced from ClinicalTrials.gov (NCT03932760). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.